MedTrace Logo

Iron Aid IPS on Performance, Fatigue and Iron Levels During 12 Weeks of Supplementation and Aerobic Training

NCT03523455 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2018-08-08

No results posted yet for this study

Summary

Participants are required to undergo a screening and qualification before beginning the study. Once qualified, baseline testing is completed in the laboratory. This testing includes: body composition measurements, a blood draw, questionnaires, a VO2 max test, and a time to exhaustion trial. This testing is repeated during week 4 and week 12. At week 8, subjects complete a blood draw and questionnaires only. During the 12 week period, participants will follow an endurance exercise program in which they will train 4 days per week. This is a double-blind study in which participants are randomized into either the placebo or supplement group. They are instructed to ingest the supplement once a day at breakfast. Diet logs are also monitored throughout the duration of the study with the restriction of no red meat.

Conditions

  • Iron-deficiency

Interventions

DIETARY_SUPPLEMENT

Iron Aid IPS (Iron Protein Succinylate)

Taken orally in capsule form

OTHER

Sugar Pill

Taken orally in capsule form

Sponsors & Collaborators

  • ChemiNutra

    collaborator UNKNOWN

  • University of Mary Hardin-Baylor

    lead OTHER

Principal Investigators

  • Lemuel W Taylor, PhD · UMHB Human Performance Lab

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-29
Primary Completion
2017-11-11
Completion
2017-11-11

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03523455 on ClinicalTrials.gov